An Open Label, Multi-Center, Follow-on Study Examining the Long-Term Safety and Efficacy of Insulin VIAject™ in Subjects With Type 2 Diabetes Mellitus

计划入组 116 人 · 首次发布于 2009 年 4 月 3 日

An Open Label, Multi-Center, Follow-on Study Examining the Long-Term Safety and Efficacy of Insulin VIAject™ in Subjects With Type 1 Diabetes Mellitus

计划入组 233 人 · 首次发布于 2009 年 4 月 3 日

Effect of F2695 on Brain Activity Measured by Functional Magnetic Resonance Imaging

计划入组 17 人 · 首次发布于 2014 年 10 月 17 日

Bracco's VueJect Receives FDA 510(k) Clearance and Health Canada Authorization as First Dedicated Ultrasound Contrast Delivery System for Cardiology Imaging

FDA Advisers Reject New Use for Pacira Nerve Block

BD Completes 50-Subject Clinical Trial for Libertas Wearable Injector System